drugset / Trial / NCT05459649
Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia
RandomizedParallel-groupSingle-blindTreatment
Summary
Randomized, open-label, multicenter study to compare the efficacy and safety of cyclosporin plus standard steroid compared to standard steroid monotherapy for the first-line treatment of adults with primary immune thrombocytopenia (ITP).
Timeline
- Start
- 2022-07-20
- Primary completion
- 2024-07-20
- Completion
- 2025-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 2.5 mg/kg | Oral |
| Subject | Prednisone | Other / unclassified | 40 mg | Oral |